Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

Author(s):
Reijneveld, J.C.; Taphoorn, M.J.B.; Coens, C.; Bromberg, J.E.C.; Mason, W.P.; Hoang-Xuan, K.; Ryan, G.; Hassel, M. ben; Enting, R.H.; Brandes, A.A.; Wick, A.; Chinot, O.; Reni, M.; Kantor, G.; Thiessen, B.; Klein, M.; Verger, E.; Borchers, C.; Hau, P.; Back, M.; Smits, A.; Golfinopoulos, V.; Gorlia, T.; Bottomley, A.; Stupp, R.; Baumert, B.G.
Published
2016
Publication type
Article / Letter to editor
Date issued
2016-11-30
Language
English
Is part of
The Lancet Oncology (2016), Vol. 17, no. 11, p. 1533-1542
hdl
1887/112666
doi
10.1016/S1470-2045(16)30305-9